Abstract: Systems and methods are disclosed for packing optimization and visualization.

Abstract: Systems and methods are disclosed for packing optimization and visualization.

Abstract: A water main tapping device and method includes a saddle body including an arcuate portion between a first end and a second end, wherein the saddle body includes a saddle opening at a location between the first end and the second end, and a corporation stop body formed integrally with and extending from the saddle body. The corporation stop body includes a base with an inlet cavity in fluid communication with the saddle opening, a housing extending from the base and having a valve cavity in which a rotatable valve is positioned and which is in fluid communication with the inlet cavity, and a connector end extending from the housing and including an outlet in fluid communication with the valve cavity.

Abstract: Systems and methods are disclosed for packing optimization and visualization.

Abstract: A water main tapping device and method includes a saddle body including an arcuate portion between a first end and a second end, wherein the saddle body includes a saddle opening at a location between the first end and the second end, and a corporation stop body formed integrally with and extending from the saddle body. The corporation stop body includes a base with an inlet cavity in fluid communication with the saddle opening, a housing extending from the base and having a valve cavity in which a rotatable valve is positioned and which is in fluid communication with the inlet cavity, and a connector end extending from the housing and including an outlet in fluid communication with the valve cavity.

Abstract: Systems and methods are disclosed for packing optimization and visualization.

Abstract: Systems and methods are disclosed for packing optimization and visualization.

Abstract: The present invention is directed to stable protein derivatives, e.g., antibodies, antibody fragments or peptides, with at least one free thiol group coupled to N-acetyl-L-cysteine, N-ethyl-maleimide, or cysteine and the methods of making such derivatives. In addition, stable liquid pharmaceutical formulations comprising such proteins or their derivatives and stable lyophilized pharmaceutical formulations comprising such proteins are provided. The present invention is also directed to a method of making a stable Fab? fragment of an antibody and a method of controlling vascularization in injured or cancerous tissue comprising applying to the injured tissue one or more doses of the pharmaceutical formulations.